SonoSite Appoints John Bowers, Senior Vice President, Strategic Development and Patient Safety Innovations

SonoSite, Inc. (NASDAQ:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, today announced the appointment of John S. Bowers, Jr. as Senior Vice President of Strategic Development and Patient Safety Innovations.

Mr. Bowers brings a depth of experience to SonoSite. With more than 20 years in the medical technology industry, he has held a number of general management, business development and sales management leadership roles. Most recently, Mr. Bowers served as the President and CEO of Northstar Neuroscience, Inc., a publicly traded medical device company specializing in the development of treatments for neurological diseases and disorders. Prior to Northstar, he spent 14 years at Guidant Corporation and Eli Lilly in management positions of increasing responsibility. Mr. Bowers holds a bachelor’s degree in Economics-Accounting from Gonzaga University and earned his M.B.A from Harvard University.

“I am excited to welcome John to the SonoSite team,” said Kevin M. Goodwin, SonoSite President and CEO. “His addition marks a new era for the company as we sharpen our focus on strategic planning and patient safety. His wealth of experience will be well utilized as he drives product initiatives to cost effectively deliver patient safety practices, optimize market strategies for future products, and ultimately, direct the company’s corporate development activities to identify growth strategies for point-of-care ultrasound.”

About SonoSite

SonoSite, Inc. (www.sonosite.com) is the innovator and world leader in hand-carried ultrasound. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care. The company employs approximately 750 people worldwide.